| Issuer Information | ||
| 1 | Issuer: | Íslandsbanki hf |
| 2 | Org. no: | 491008-0160 |
| 3 | LEI | 549300PZMFIQR79Q0T97 |
| Issue Information | ||
| 4 | Symbol (Ticker) | ISLA 18 1211 |
| 5 | ISIN code | IS0000029460 |
| 6 | CFI code | D-Y-Z-U-X-R |
| 7 | FISN númer | ISLANDSBANKI HF/ZERO CPN B 20181211 |
| 8 | Bonds/bills: | Bills |
| 9 | Total issued amount | 1.760.000.000 |
| 10 | Amount issued at this time | 1.760.000.000 |
| 11 | Denomination in CSD | 20.000.000 |
| Amortization - Cash Flow | ||
| 12 | Amortization type | Zero Coupon Bond |
| 13 | Amortization type, if other | |
| 14 | Currency | ISK |
| 15 | Currency, if other | |
| 16 | Issue date | June 12, 2018 |
| 17 | First ordinary installment date | December 11, 2018 |
| 18 | Total number of installments | 1 |
| 19 | Installment frequency | 1 |
| 20 | Maturity date | December 11, 2018 |
| 21 | Interest rate | N/A |
| 22 | Floating interest rate, if applicable | |
| 23 | Floating interest rate, if other | |
| 24 | Premium | N/A |
| 25 | Simple/compound interest | Simple Interest |
| 26 | Simple/compound, if other | |
| 27 | Day count convention | ACT/360 |
| 28 | Day count convention, if other | |
| 29 | Interest from date | N/A |
| 30 | First ordinary coupon date | N/A |
| 31 | Coupon frequency | N/A |
| 32 | Total number of coupon payments | N/A |
| 33 | If irregular cash flow, then how | |
| 34 | Dirty price / clean price | Dirty Price |
| 35 | If payment date is a bank holiday, does payment include accrued interest for days missing until next business day? | No |
| Indexing | ||
| 36 | Indexed | No |
| 37 | Name of index | |
| 38 | Daily index or monthly index | |
| 39 | Daily index or monthly index, if other | |
| 40 | Base index value | |
| 41 | Index base date | |
| Other Information | ||
| 42 | Call option | No |
| 43 | Put option | No |
| 44 | Convertible | No |
| 45 | Credit rating (rating agency, date) | N/A |
| 46 | Additional information | N/A |
| Admission to Trading | ||
| 47 | Registered at CSD | Yes |
| 48 | Securities depository | Nasdaq CSD Iceland |
| 49 | Date of Application for Admission to Trading | June 11, 2018 |
| 50 | Date of Approval of Application for Admission to Trading | June 12, 2018 |
| 51 | Date of admission to trading | June 13, 2018 |
| 52 | Order book ID | 156442 |
| 53 | Instrument subtype | Corporate bonds |
| 54 | Market | OMX ICE DP Fixed Income |
| 55 | List population name | OMX ICE Bank Bills |
| 56 | Static volatility guards | No |
| 57 | Dynamic volatility guards | No |
| 58 | MiFIR identifier | BOND - Bonds |
| 59 | Bond type | CRPB - Corporate Bond |
Íslandsbanki hf. - Bank bill (ISLA 18 1211) admitted to
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Investors Urged to Explore Rights in Symbotic Class Action
Understanding the Class Action Lawsuit for Symbotic Inc. Investors in Symbotic Inc. (NASDAQ:SYM) are currently facing significant concerns regarding recent developments within the company. A class action lawsuit has been initiated in the U.S. District Court for the District of Massachusetts, aimed at those investors who purchased securities between the specified dates....
Continue Reading
Egypt's President Sisi Reflects on IMF Agreement Amid Crisis
Egypt's Economic Landscape Under Scrutiny In light of unprecedented regional challenges, Egyptian President Abdel Fattah al-Sisi has raised concerns regarding the nation's ongoing agreement with the International Monetary Fund (IMF). The $8 billion financial support program, signed amidst economic turbulence, may be revisited if the expectations of global financial...
Continue Reading
Insights into Mastercard's Recent Options Trading Dynamics
Mastercard's Options Activity: What's Happening? Recently, the options market has seen significant movement from large investors, commonly referred to as "whales." This activity indicates a largely bearish sentiment towards Mastercard. In our analysis of the recent trades involving Mastercard MA, we identified eight significant transactions. Interestingly, none of these...
Continue Reading
Coave Therapeutics Raises Significant Funding for Genetic Breakthroughs
Coave Therapeutics Secures Major Investment to Propel Innovation Coave Therapeutics, a pioneer in the realm of genetic medicines, has successfully raised €32 million (approximately $33 million) in a Series A financing round. This funding was notably co-led by Novo Holdings A/S and Bpifrance, with additional contributions from leading investors in the US and EU,...
Continue Reading
Strive Expands with MSTR True North Acquisition and Leadership Change
Strive's Exciting Acquisition of MSTR True North Inc. Strive, Inc. has made waves in the financial technology sector with its strategic acquisition of MSTR True North Inc. This move marks a pivotal moment in Strive's journey, enhancing its commitment to Bitcoin advocacy and marking a significant step forward in the realm of Digital Capital and Digital Credit. Leadership...
Continue Reading